Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avalanche Biotechnologies Inc.

Division of Adverum Biotechnologies Inc.
www.avalanchebiotech.com

Latest From Avalanche Biotechnologies Inc.

Start-Up Quarterly Statistics, Q1 2016

Start-ups raised $1.8 billion in Q1 2016. Biopharma companies penned 33 alliances; 14 acquisitions were signed (11 in the biopharma industry).

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, March 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.

BioPharmaceutical Medical Device

Deal Watch: GSK Accelerates TCR Collaboration With Adaptimmune

Merger combines troubled Avalanche's resources with Annapurna's brimming pipeline. Janssen sells its BetaLogic stem-cell IP to partner ViaCyte to hasten development of a stem cell therapeutic for diabetes.

BioPharmaceutical Deals

Deals Shaping the Medical Industry, February 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Adverum Biotechnologies Inc.
  • Senior Management
  • Paul B Cleveland, CEO, Interim CFO
    Samuel B Barone, MD, CMO
    Hans P Hull, JD, SVP, Bus Ops
    Mehdi Gasmi, PhD, Interim CSO
    Roman G Rubio, MD, SVP & Head Translational Medicine
  • Contact Info
  • Avalanche Biotechnologies Inc.
    Phone: (650) 272-6269
    1035 O’Brien Dr.
    Ste. A
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register